NY
Nuralli Yunus Gangrekar
About Nuralli Yunus Gangrekar
Data last updated:
Nuralli Yunus Gangrekar is a Director at Flowrich Pharma Private Limited (since 2021), Director at Surgence Pharmatech Private Limited (since 2019) and Designated Partner at Synrix Biotech Llp (since 2025). The companies operate in Pharma and Trading. The 2 current companies with reported revenue have a combined latest revenue of ₹4.99 Cr; the largest is Flowrich Pharma Private Limited at ₹2.56 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Flowrich Pharma Private Limited U51909MH2020PTC348012 | Director | 01 Jan 2021 | 2020 | ₹2.56 Cr (FY 2024) | Active |
| Surgence Pharmatech Private Limited U51909MH2019PTC335180 | Director | 30 Dec 2019 | 2019 | ₹2.42 Cr (FY 2025) | Active |
| Synrix Biotech Llp ACS-4922 | Designated Partner | 05 Nov 2025 | 2025 | Active |
Board colleagues of Nuralli Yunus Gangrekar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Vibha Devi Kumar | 09707805 | Flowrich Pharma Private Limited | Additional Director |
| Anwari Nuralli Gangrekar | 10637876 | Surgence Pharmatech Private Limited | Director |
| Abdur Rehman | 11368845 | Synrix Biotech Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nuralli Yunus Gangrekar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nuralli Yunus Gangrekar
Nuralli Yunus Gangrekar currently holds 3 directorships: Flowrich Pharma Private Limited (Director, since 01 Jan 2021, revenue ₹2.56 Cr (FY 2024)); Surgence Pharmatech Private Limited (Director, since 30 Dec 2019, revenue ₹2.42 Cr (FY 2025)); Synrix Biotech Llp (Designated Partner, since 05 Nov 2025).
Nuralli Yunus Gangrekar was first appointed on 30 Dec 2019 as Director at Surgence Pharmatech Private Limited. The most recent appointment on record is 05 Nov 2025 at Synrix Biotech Llp.
The 2 current companies of Nuralli Yunus Gangrekar that report revenue have a combined latest revenue of ₹4.99 Cr: Flowrich Pharma Private Limited ₹2.56 Cr (FY 2024); Surgence Pharmatech Private Limited ₹2.42 Cr (FY 2025).
The current boards of Nuralli Yunus Gangrekar's companies include Vibha Devi Kumar (Flowrich Pharma Private Limited), Anwari Nuralli Gangrekar (Surgence Pharmatech Private Limited), Abdur Rehman (Synrix Biotech Llp).